BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.27% |
| 2 | Financials | 8.4% |
| 3 | Industrials | 5.97% |
| 4 | Consumer Discretionary | 5.96% |
| 5 | Healthcare | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORBK
2826
DELISTED
Orbotech Ltd
ORBK
| $26.4K | ﹤0.01% |
1,267
+25
| +2% | +$483 |
|
|
PFNX
2827
DELISTED
Pfenex Inc.
PFNX
| $26.3K | ﹤0.01% |
+1,358
| New | +$22.8K |
|
2828
B2Gold
BTG
$6.7B
| $26.3K | ﹤0.01% |
14,438
-4,500
| -24% | -$7.29K |
|
|
PRTK
2829
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $26.2K | ﹤0.01% |
+1,015
| New | +$28.8K |
|
2830
Future Fuel
FF
$249M
| $26.1K | ﹤0.01% |
2,031
+1,512
| +291% | +$17.7K |
|
|
MRTX
2831
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $26.1K | ﹤0.01% |
829
+631
| +319% | +$18.6K |
|
2832
The Bancorp
TBBK
$2.82B
| $26K | ﹤0.01% |
2,804
+2,034
| +264% | +$19.7K |
|
2833
Dime Commercial Bancshares
DCOM
$1.82B
| $26K | ﹤0.01% |
974
+702
| +258% | +$18K |
|
|
KEYW
2834
DELISTED
The KEYW Holding Corporation
KEYW
| $26K | ﹤0.01% |
2,787
+2,003
| +255% | +$17.9K |
|
2835
CorVel
CRVL
$3.25B
| $26K | ﹤0.01% |
2,433
+1,653
| +212% | +$19.2K |
|
2836
Independent Bank Corp
IBCP
$854M
| $25.9K | ﹤0.01% |
1,911
+1,201
| +169% | +$16K |
|
|
CPRX
2837
DELISTED
Catalyst Pharmaceutical
CPRX
| $25.9K | ﹤0.01% |
+6,267
| New | +$25K |
|
|
ARC
2838
DELISTED
ARC Document Solutions, Inc.
ARC
| $25.8K | ﹤0.01% |
3,395
+2,431
| +252% | +$19.8K |
|
|
RGLS
2839
DELISTED
Regulus Therapeutics
RGLS
| $25.8K | ﹤0.01% |
20
+17
| +567% | +$27.4K |
|
|
METR
2840
DELISTED
METRO BANCORP, INC COMMON STOCK
METR
| $25.8K | ﹤0.01% |
986
+658
| +201% | +$17.2K |
|
|
ACRE
2841
Ares Commercial Real Estate
ACRE
$264M
| $25.7K | ﹤0.01% |
2,256
+1,584
| +236% | +$18.2K |
|
|
ANTH
2842
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $25.7K | ﹤0.01% |
+373
| New | +$17.3K |
|
|
GCAP
2843
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $25.7K | ﹤0.01% |
2,685
+2,149
| +401% | +$21.1K |
|
|
TSE
2844
DELISTED
Trinseo
TSE
| $25.6K | ﹤0.01% |
954
+678
| +246% | +$17.4K |
|
2845
Vera Bradley
VRA
$94.7M
| $25.6K | ﹤0.01% |
2,272
+1,763
| +346% | +$23.9K |
|
2846
First Community Bankshares
FCBC
$933M
| $25.6K | ﹤0.01% |
1,403
+1,015
| +262% | +$17.6K |
|
|
BBOX
2847
DELISTED
Black Box Corp
BBOX
| $25.6K | ﹤0.01% |
1,278
+921
| +258% | +$18.8K |
|
|
VIVS
2848
VivoSim Labs
VIVS
$1.15M
| $25.6K | ﹤0.01% |
28
+22
| +367% | +$24.6K |
|
|
SMRT
2849
DELISTED
Stein Mart Inc
SMRT
| $25.6K | ﹤0.01% |
2,441
+1,786
| +273% | +$20.5K |
|
|
FRM
2850
DELISTED
FURMANITE CORPORATION COM
FRM
| $25.5K | ﹤0.01% |
3,142
+2,272
| +261% | +$18.7K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.